ArticleBMJ open2021

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study).

Dafna Yahav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.